Value Sense
HSCS
Heart Test Laboratories, Inc. (HSCS)
Last Price$2.95.0%
Market Cap$2,541.3M
LTM Rule of 40 (EBIT margin)
(50,887.9%)
5Y avg
(9,969.3%)
Medical - Devices industry median
(17.8%)
Stock quality & Intrinsic value
5/10
114.5% undervalued
HSCS
is 11,448.4% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Heart Test Laboratories, Inc. Rule of 40 (EBIT margin)

Annual
Quarterly
LTM
Industry median
Company stand-alone
HSCS
Healthcare
Crunching data... Almost there!
Apr'20Apr'21Apr'22Apr'23Apr'24
Rule of 40 (EBIT margin)
0.0%
(10,090.3%)
(32,809.5%)
(118,762.5%)
(33,640.8%)
HSCS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for HSCS and see if it's the right time to invest.
Dive in

Heart Test Laboratories, Inc. (HSCS) Rule of 40 (EBIT margin) comparison analysis

General

LTM Rule of 40 (EBIT margin)

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Heart Test Laboratories, Inc. logo
Heart Test Laboratories, Inc.HSCS
(50,887.9%)
261.2%
(99.7%)
(35,511.9%)
Median Peer Set
21.4%
4.2%
59.2%
12.5%
Boston Scientific Corporation logo
Boston Scientific CorporationBSX
34.6%
17.6%
16.7%
11.1%
Insulet Corporation logo
Insulet CorporationPODD
28.2%
22.1%
101.7%
20.2%
Stryker Corporation logo
Stryker CorporationSYK
27.0%
10.2%
(5.8%)
13.2%
DexCom, Inc. logo
DexCom, Inc.DXCM
26.2%
11.3%
(1.4%)
14.3%
Edwards Lifesciences Corporation logo
Edwards Lifesciences CorporationEW
21.7%
(9.4%)
202.2%
76.7%
Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc.ZBH
21.2%
3.8%
(9.4%)
11.8%
Abbott Laboratories logo
Abbott LaboratoriesABT
21.1%
4.6%
134.5%
31.9%
Medtronic plc logo
Medtronic plcMDT
20.9%
3.6%
(2.1%)
11.4%
STERIS plc logo
STERIS plcSTE
17.5%
3.6%
257.9%
7.4%
Koninklijke Philips N.V. logo
Koninklijke Philips N.V.PHG
2.1%
(0.8%)
122.5%
(3.9%)

HSCS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Apr'20Apr'21Apr'22Apr'23Apr'24
Revenue
% growth
0.1
0.0%
0.0
(60.1%)
0.0
(43.9%)
0.0
(64.2%)
0.0
261.2%
Cost of Goods Sold (COGS)0.00.00.00.00.0
Gross Profit
% margin
0.0
27.6%
0.0
58.3%
0.0
45.1%
0.0
45.7%
0.0
67.3%
Operating Expenses3.82.64.76.16.3
Research & Development Expenses (R&D)2.01.73.02.52.9
Selling, General & Administrative Expenses (SG&A)1.80.91.73.73.4
Operating Income
% margin
(3.8)
(5,949.0%)
(2.6)
(10,030.2%)
(4.7)
(32,765.6%)
(6.1)
(118,698.3%)
(6.3)
(33,902.0%)
Interest Income0.00.10.40.20.0
Interest Expense0.00.10.40.20.4
Pre-tax Income(3.8)(2.5)(4.8)(6.4)(6.6)
Income Tax
% effective tax rate
0.0
(0.6%)
0.1
(5.3%)
(0.3)
5.2%
484.5
(7,624.8%)
0.0
0.0%
Net Income
% margin
(3.8)
(5,973.4%)
(2.6)
(10,081.1%)
(4.6)
(31,851.8%)
(490.9)
(9,531,151.3%)
(6.6)
(35,511.9%)
EPS(115.69)(77.89)(137.94)(6,173.88)(18.74)
Diluted EPS(115.69)(77.89)(137.94)(6,173.88)(18.74)
EBITDA
% margin
(3.7)
(5,834.2%)
(2.3)
(8,928.7%)
(4.4)
(30,822.2%)
(6.1)
(118,139.8%)
(6.2)
(33,096.7%)

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Heart Test Laboratories, Inc.'s Rule of 40 (EBIT margin)?

As of today, Microsoft Corp's last 12-month Rule of 40 (EBIT margin) is (50,887.9%), based on the financial report for Oct 31, 2024 (Q4’2024). The average annual Rule of 40 (EBIT margin) for Heart Test Laboratories, Inc. have been (9,969.3%) over the past three years, and (7,477.0%) over the past five years.

2) Is Heart Test Laboratories, Inc.'s Rule of 40 (EBIT margin) Good?

As of today, Heart Test Laboratories, Inc.'s Rule of 40 (EBIT margin) is (50,887.9%), which is lower than industry median of (17.8%). It indicates that Heart Test Laboratories, Inc.'s Rule of 40 (EBIT margin) is Bad.

3) How does Heart Test Laboratories, Inc.'s Rule of 40 (EBIT margin) compare to its peers?

As of today, Heart Test Laboratories, Inc.'s Rule of 40 (EBIT margin) is (50,887.9%), which is lower than peer median of 21.4%. The list of peers includes BSX, PODD, SYK, DXCM, EW, ZBH, ABT, MDT, STE, PHG.